portada Amorphous Drugs: Benefits and Challenges (en Inglés)

Amorphous Drugs: Benefits and Challenges (en Inglés)

Formato

Libro Físico

Autor

Editorial

Idioma

Inglés

N° páginas

230

Encuadernación

Tapa Blanda

Dimensiones

23.4x15.6x1.3 cm

Peso

0.34 kg.

ISBN13

9783319891293

Categorías

Farmacia/prescripción/dispensación
Física de la materia condensada (física del estado líquido y del estado sólido)
Bioquímica

Amorphous Drugs: Benefits and Challenges (en Inglés)

Marzena Rams-Baron (Autor) · Renata Jachowicz (Autor) · Elena Boldyreva (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 16 a 23 días háb.

$ 265.74$ 132.87

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 132.87

Llega entre el 15 Sep y el 28 Sep a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Amorphous Drugs: Benefits and Challenges (en Inglés)"

This book explains theoretical and technological aspects of amorphous drug formulations. It is intended for all those wishing to increase their knowledge in the field of amorphous pharmaceuticals. Conversion of crystalline material into the amorphous state, as described in this book, is a way to overcome limited water solubility of drug formulations, in this way enhancing the chemical activity and bioavailability inside the body. Written by experts from various fields and backgrounds, the book introduces to fundamental physical aspects (explaining differences between the ordered and the disordered solid states, the enhancement of solubility resulting from drugs amorphization, physical instability and how it can be overcome) as well as preparation and formulation procedures to produce and stabilize amorphous pharmaceuticals. Readers will thus gain a well-funded understanding and find a multi-faceted discussion of the properties and advantages of amorphous drugs and of the challenges in producing and stabilizing them. The book is an ideal source of information for researchers and students as well as professionals engaged in research and development of amorphous pharmaceutical products.